comparemela.com

Latest Breaking News On - Nasus pharma - Page 7 : comparemela.com

2 New Nasal Sprays That Kill COVID-19 Virus Are Looking Remarkably Effective

2 New Nasal Sprays That Kill COVID-19 Virus Are Looking Remarkably Effective Feb 23, 2021 During the Jewish holiday of Rosh Hashanah 2020, Israeli researchers realized they had a solid real-world opportunity to try out a nasal spray they were developing as a COVID-19 defense. As the Jewish faith’s new year, tens of thousands would be traveling and attending synagogue and related festivals in the densely populated city of Bnei Brak making it an ideal testing site. Approved in Israel, Taffix, a spray created by Nasus Pharma, creates a barrier of both mechanical and chemical protection for around five hours when inhaled through the nose. It was this spray that its co-creator, Dalia Megiddo, offered to a Bnei Brak rabbi for use in the festivals.

21 February 2021 Coronavirus Charts and News: Pfizer Vaccine 99% Effective In Preventing Serious Disease, Death Israeli-Made Nasal Spray Reduced Infection At Mass Gathering

21 February 2021 Coronavirus Charts and News: Pfizer Vaccine 99% Effective In Preventing Serious Disease, Death Israeli-Made Nasal Spray Reduced Infection At Mass Gathering
econintersect.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from econintersect.com Daily Mail and Mail on Sunday newspapers.

Study: Israeli anti-COVID nasal spray reduced infection risk at mass gathering

1,410 shares An illustration by Nasus Pharma, makers of the Taffix spray, showing the novel coronavirus entering the nasal cavity. (Screenshot) An Israeli-made nasal spray appears to have contributed to a reduced COVID-19 infection rate among ultra-Orthodox members of a synagogue in Bnei Brak amid Rosh Hashanah festivities last year, a new trial has shown. Of 83 worshipers who used the spray as instructed before Rosh Hashanah prayers and for the following two weeks, just two contracted the highly contagious virus, in a real-world test of the substance which is designed to create a protective gel layer over the nasal mucosa to blocks viruses from infecting the nasal cells. The study was conducted by makers of the Taffix spray, Nasus Pharma, along with scientists from the University of Haifa, the University of Virginia, and the Hadassah Medical Center in Jerusalem. The full study was initially published in November 2020, with an updated version posted last month.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.